Henrik Carlsson

Sökresultat

• 2021

  ARTSCAN III: A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer

  Gebre-Medhin, M., Brun, E., Engström, P., Cange, H. H., Hammarstedt-Nordenvall, L., Reizenstein, J., Nyman, J., Abel, E., Friesland, S., Sjödin, H., Carlsson, H., Söderkvist, K., Thomasson, M., Zackrisson, B. & Nilsson, P., 2021, I: Journal of Clinical Oncology. 39, 1, s. 38-47 10 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cetuximab 100%
  • Squamous Cell Neoplasms 99%
  • Chemoradiotherapy 85%
  • Head and Neck Neoplasms 80%
  • Cisplatin 71%
  28 Citeringar (SciVal)